1. Ad Hoc FDA Dementia Assessment Task Force. Meeting report: Antidementia drug assessment symposium. Neurobiol Aging 1991;12:379–382.

2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed. (revised). Washington, DC: American Psychiatric Association, 1987.

3. Berg L, Miller JP, Bary J, Rubin EH, Morris JC, Figiel G. Mild senile dementia of the Alzheimer type. 4. Evaluation of intervention. Ann Neurol 1992;31:242–249.

4. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968;114:797–811.

5. Burke WJ, Miller JP, Rubin EH, Morris JC, Coben LA, Duchek J, Wittels IG, Berg L. Reliability of the Washington University clinical dementia rating. Arch Neurol 1988;45:31–32.

6. Chui HC, Teng EL, Henderson VW, Moy AC. Clinical subtypes of dementia of the Alzheimer type. Neurology 1985;35:1544–1550.

7. Clinical Research Working Group from the Pharmaceutical Industry on Dementia. Recommendations for clinical drug trials in dementia. Dementia 1990;1:292–295.

8. Coblentz JM, Mattis S, Zingesser LH, Kasoff SS, Wisniewski HM, Katzman R. Presenile dementia: clinical aspects and evaluation of cerebrospinal fluid dynamics. Arch Neurol 1973;29:299–308.

9. Cohen-Mansfield J. Agitated behaviors in the elderly. II. Preliminary results in the cognitively deteriorated. J Am Geriatr Soc 1986;34:722–727.

10. CPMP Working Party on Efficacy of Medicinal Products. Antidementia medicinal products. Commission of the European Communities, Brussels, November 1992.

11. Davis KL, Thal LJ, Gamzu ER, et al. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. N Engl J Med 1992;327:1253–1259.

12. Davis PC, Gray L, Albert M, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part III. Reliability of a standardized MRI evaluation of Alzheimer's disease. Neurology 1992;42:1676–1680.

13. Erzigkeit H. The SKT—a short cognitive performance test as an instrument for the assessment of clinical efficacy of cognitive enhancers. In: Bergner W, Reisberg B, eds. Diagnosis and treatment of senile dementia. Heidelberg: Springer, 1989;164–174.

14. Farlow M, Gracon SI, Hershey LA, et al. A controlled trial of tacrine in Alzheimer's disease. JAMA 1992;268:2523–2529.

15. Ferris SH, Flicker C, Riesberg B. NYU computerized test battery for assessing cognition in aging and dementia. Psychopharmacol Bull 1988;24:699–702.

16. Folstein M, Anthony JC, Parhad I, Duffy B, Gruenberg EM. The meaning of cognitive impairment in the elderly. J Am Geriatr Soc 1985;33:228–235.

17. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental-State." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.

18. Galasko D, Corey-Bloom J, Thal LJ. Monitoring progression in Alzheimer's disease. J Am Geriatr Soc 1991;39:932–941.

19. Green CR, Mohs RC, Schmeidler J, Aryan M, Davis KL. Functional decline in Alzheimer's disease: a longitudinal study. J Am Geriatr Soc 1993;41:654–661.

20. Greenwald BS, Kramer-Ginzberg E, Marin DB, Laitman LB, Herman CK, Mohs RC, Davis KL. Dementia with coexistent depression. Am J Psychiatry 1989;146:1472–1478.

21. Gurel L, Linn MW, Linn BS. Physical and mental impairment-of-function evaluation in the aged: the PAMIE scale. J Gerontol 1972;27:83–90.

22. Guy W, ed. ECDEU assessment manual. Rockville, MD: U.S. Department of Health Education and Welfare Publication No. (ADM) 76-338, 1976.

23. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62.

24. Inouye SK, Albert MS, Mohs RC, Sun K, Berkman L. Cognitive performance in a high-functioning community-dwelling elderly population. J Gerontol: Med Sci 1993;48:M146–M151.

25. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. JAMA 1963;185:914–919.

26. Katzman R. Alzheimer's disease. N Engl J Med 1986;314:964–973.

27. Katzman R, Aronson M, Fild P, Kawas C, Brown T, Morgenstern H, Frishman W, Gidez L, Eder H, Ooi WL. Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol 1989;25:317–324.

28. Katzman R, Brown T, Thal LJ, et al. Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease. Ann Neurol 1988;24:384–389.

29. Kim YS, Nibbelink DW, Overall JE. Factor structure and scoring of the SKT test battery. J Clin Psychol 1993;49:61–71.

30. Kramer-Ginzberg E, Mohs RC, Aryan M, Lobel D, Silverman JM, Davidson M, Davis KL. Predictors of course for Alzheimer patients in a longitudinal study. Psychopharmacol Bull 1988;24:458–462.

31. Larrabee GJ, Crook T. A computerized everyday memory battery for assessing treatment effects. Psychopharmacol Bull 1988;24: 695–697.

32. Larsson T, Sjogren T, Jacobson G. Senile dementia. Acta Psychiatr Scand 1963;39(Suppl 167):3–259.

33. Lawton MP, Brodie EM. Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist 1969;23:349–357.

34. Leber P. Guidelines for the clinical evaluation of antidementia drugs, first draft. Rockville, MD: U.S. Food and Drug Administration, 1990.

35. Loewenstein DA, Amigo E, Duara R, et al. A new scale for the assessment of functional status in Alzheimer's disease and related disorders. J Gerontol Psychol Sci 1989;44:P114–P121.

36. Luchins DJ, Cohen D, Hanrahan P, et al. Are there clinical differences between familial and nonfamilial Alzheimer's disease? Am J Psychiatry 1992;149:1023–1027.

37. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939–944.

38. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479–486.

39. Mohs RC. Assessment of cognitive symptoms in clinical studies of antidementia drugs (Homma A, trans.). Jpn J Geriatr Psychiatry 1991;2:1195–1201.

40. Mohs RC, Rosen WG, Davis KL. Defining treatment efficacy in patients with Alzheimer's disease. In: Corkin S, Davis KL, Growden JH, Usdin E, Wurtman RJ, eds. Alzheimer's disease: a report of progress in research. New York: Raven Press, 1982;351–356.

41. Morris JC, Edland S, Clark C, et al. Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 1993;43:2457–2465.

42. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159–1165.

43. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799–812.

44. Pearson JL, Teri L, Reifler BV, Raskind MA. Functional status and cognitive impairment in Alzheimer's patients with and without depression. J Am Geriatr Soc 1989;37:1117–1121.

45. Perry EK, Tomlinson BE, Blessed G, Bergman K, Gibson PH, Perry RH. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 1978;2:1457–1459.

46. Reifler BV, Larson E, Hanley R. Coexistence of cognitive impairment and depression in geriatric outpatients. Am J Psychiatry 1982;139:623–626.

47. Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136–1139.

48. Rosen J, Zubenko GS. Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer's disease. Biol Psychiatry 1991;29:224–232.

49. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356–1364.

50. Roth M. The natural history of mental disorder in old age. J Mental Sci 1955;101:281–301.

51. Salmon DP, Thal LJ, Butters N, Heindel WC. Longitudinal evaluation of dementia of the Alzheimer type. Neurology 1990;40:1225–1230.

52. Spiegel R, Brunner C, Ermini-Funfschilling D, Monsch A, Notter M, Puxty J, Tremmel L. A new behavioral assessment scale for geriatric out-and in-patients: the NOSGER (Nurses Observation Scale for Geriatric Patients). J Am Geriatr Soc 1991;39:339–347.

53. Stern RG, Mohs RC, Bierer LM, Silverman JM, Schmeidler J, Davidson M, Davis KL. Deterioration on the Blessed Test in Alzheimer's disease: longitudinal data and their implications for clinical trials and identification of subtypes. Psychiatry Res 1992;42:101–110.

54. Stern RG, Mohs RC, Davidson M, Schmeidler J, Silverman JM, Kramer-Ginzberg E, Searcey T, Bierer LM, Davis KL. A longitudinal study of Alzheimer's disease: measurement, rate and predictors of cognitive deterioration. Am J Psychiatry 1994;151:390–396.

55. Stern Y, Hesdorffer D, Sano M, Mayeux R. Measurement and prediction of functional capacity in Alzheimer's disease. Neurology 1990;40:8–14.

56. Stern Y, Mayeux R, Sano M, Hauser WA, Brush T. Predictors of disease course in patients with probable Alzheimer's disease. Neurology 1987;37:1649–1653.

57. Storandt M, Hill RD. Very mild senile dementia of the Alzheimer type. Arch Neurol 1989;46:383–386.

58. Sunderland T, Alterman I, Young D, Hill JL, Tariot PN, Newhouse PA, Murphy DL, Cohen RM. A new scale for the assessment of depressed mood in dementia subjects. Am J Psychiatry 1988;145:955–959.

59. Teri L, Hughes JP, Larson EB. Cognitive deterioration in Alzheimer's disease: behavioral and health factors. J Gerontol 1990;45:P58–P63.

60. Teri L, Rabins P, Whitehouse P, Berg L, Riesberg B, Sunderland T, Eichelman B, Phelps C. Management of behavior disturbance in Alzheimer disease: Current knowledge and future directions. Alzheimer's Dis Assoc Disord 1992;6:77–88.

61. Thal LJ, Grundman M, Klauber MR. Dementia: characteristics of a referral population and factors associated with progression. Neurology 1988;38:1083–1090.

62. Uhlman RF, Larson EB, Koepsell TD. Hearing impairment and cognitive decline in senile dementia of the Alzheimer's type. J Am Geriatr Soc 1986;34:207–210.

63. Wechsler D. The measurement and appraisal of adult intelligence, 4th ed. Baltimore: Williams & Wilkins, 1958.

64. Welsh KA, Butters N, Hughes J, Mohs RC, Heyman A. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol 1991;48:278–281.

65. Welsh KA, Butters N, Hughes J, Mohs RC, Heyman A. Detection and staging of dementia in Alzheimer's disease: use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Arch Neurol 1992;49:448–452.

66. Weyer G, Ihl R, Mohs RC, Schambach M, Denkel A, Kaiser-Kehl H. Validierungsuntersuchungen zu einer deutschen version der Alzheimer's Disease Assessment Scale (ADAS). Z Gerontopsychol Psychiatr 1993;6:67–81.

67. Yesavage JA, Tinklenberg JR, Hollister LE, Berger PA. Vasodilators in senile dementia: a review of the literature. Arch Gen Psychiatry 1979;36:220–223.

68. Zec RF, Landreth ES, Vicari SK, Belman J, Feldman E, Andrise A, Robbs R, Becker R, Kumar V. Alzheimer's Disease Assessment Scale: a subtest analysis. Alzheimer's Dis Assoc Disord 1992;6:164–181.